IL18 and Alzheimer disease: Activated soluble interleukin-1 receptor type II, IL-18, and caspase-1 protein in cerebrospinal fluid (CSF) with mild CI and AD patients has been found by Lindberg et al. [39], indicating that inflammasome activation may be an important step in the development of early CI.